Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor

• Published in: British journal of cancer Vol. 69; no. 5; pp. 802 - 808
• Main Authors: Nørgaard, P, Damstrup, L, Rygaard, K, Spang-Thomsen, M, Skovgaard Poulsen, H
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 01.05.1994
• Subjects: Carcinoma, Small Cell - chemistry; Carcinoma, Small Cell - pathology; Cell Division - drug effects; Cell Nucleus - chemistry; Humans; Lung Neoplasms - chemistry; Lung Neoplasms - pathology; Receptors, Transforming Growth Factor beta - analysis; Retinoblastoma Protein - analysis; Transforming Growth Factor beta - pharmacology; Tumor Cells, Cultured
• ISSN: 0007-0920; 1532-1827

Nine human small-cell lung cancer cell lines were treated with transforming growth factor beta 1 (TGF-beta 1). Seven of the cell lines expressed receptors for transforming growth factor beta (TGF-beta-r) in different combinations between the three human subtypes I, II and III, and two were receptor negative. Growth suppression was induced by TGF-beta 1 exclusively in the five cell lines expressing the type II receptor. For the first time growth suppression by TGF-beta 1 of a cell line expressing the type II receptor without coexpression of the type I receptor is reported. No effect on growth was observed in two cell lines expressing only type III receptor and in TGF-beta-r negative cell lines. In two cell lines expressing all three receptor types, growth suppression was accompanied by morphological changes. To evaluate the possible involvement of the retinoblastoma protein (pRb) in mediating the growth-suppressive effect of TGF-beta 1, the expression of functional pRb, as characterised by nuclear localisation, was examined by immunocytochemistry. Nuclear association of pRb was only seen in two of the five TGF-beta 1-responsive cell lines. These results indicate that in SCLC pRb is not required for mediation of TGF-beta 1-induced growth suppression.